DocuSign (NASDAQ:DOCU) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPS

DocuSign (NASDAQ:DOCU) posted its quarterly earnings data on Thursday. The company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.81 by $0.09, Briefing.com reports. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business had revenue of $763.65 million for the quarter, compared to the consensus estimate of $748.79 million. During the same quarter in the prior year, the business earned $0.82 earnings per share. DocuSign’s revenue for the quarter was up 7.6% on a year-over-year basis. DocuSign updated its FY 2026 guidance to EPS and its Q2 2026 guidance to EPS.

DocuSign Stock Performance

Shares of DOCU stock opened at $75.28 on Friday. The company has a market capitalization of $15.24 billion, a PE ratio of 15.52, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21. DocuSign has a 52-week low of $48.70 and a 52-week high of $107.86. The business’s fifty day moving average is $82.08 and its 200 day moving average is $86.22.

Insider Activity

In other DocuSign news, Director Teresa Briggs sold 534 shares of the business’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $87.41, for a total value of $46,676.94. Following the sale, the director now owns 8,270 shares in the company, valued at $722,880.70. The trade was a 6.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Blake Jeffrey Grayson sold 16,111 shares of the business’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $83.20, for a total transaction of $1,340,435.20. Following the completion of the sale, the chief financial officer now owns 93,960 shares in the company, valued at approximately $7,817,472. The trade was a 14.64% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 47,851 shares of company stock valued at $3,912,239. 1.01% of the stock is currently owned by insiders.

Institutional Trading of DocuSign

An institutional investor recently raised its position in DocuSign stock. NewEdge Advisors LLC grew its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU) by 36.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,202 shares of the company’s stock after buying an additional 2,457 shares during the quarter. NewEdge Advisors LLC’s holdings in DocuSign were worth $749,000 at the end of the most recent reporting period. Institutional investors own 77.64% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on DOCU. Bank of America dropped their price objective on DocuSign from $88.00 to $85.00 and set a “neutral” rating on the stock in a research note on Friday. Hsbc Global Res upgraded DocuSign from a “moderate sell” rating to a “hold” rating in a research note on Friday, April 11th. Robert W. Baird dropped their price objective on DocuSign from $93.00 to $85.00 and set a “neutral” rating on the stock in a research note on Friday. HSBC upgraded DocuSign from a “reduce” rating to a “hold” rating and set a $70.00 target price on the stock in a research report on Friday, April 11th. Finally, UBS Group dropped their target price on DocuSign from $85.00 to $80.00 and set a “neutral” rating on the stock in a research report on Friday. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $89.15.

DocuSign announced that its Board of Directors has initiated a share buyback program on Thursday, June 5th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 6.6% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its stock is undervalued.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.